Karo Pharma AB (publ)
KARBF News Today: Stay Updated with the Latest Karo Pharma AB (publ) News in Real Time
Find KARBF news now at Meyka AI. Stay informed with the latest Karo Pharma AB (publ) stocks updates, including price news, market analysis, and expert insights.
BAYN.DE Bayer AG (XETRA) pre-market: earnings due 04 Mar 2026, guidance key
Pre-market BAYN.DE stock preview ahead of 04 Mar 2026 earnings; key metrics, Meyka AI forecast and price targets
INR 130.85 CHEMOPH.BO Chemo Pharma (BSE) 26 Feb 2026: oversold bounce watch
Oversold bounce setup for CHEMOPH.BO stock at INR 130.85 on BSE — short-term target INR 144.37
4597.T stock: Solasia Pharma JPX +10% to JPY 33.00 on 54.51M volume: catalysts 26 Feb 2026
4597.T stock jumps to JPY 33.00 on heavy volume; analysis, Meyka AI forecast and risks for Solasia Pharma
Barclays keeps Overweight on Sandvik AB (publ) SDVKY; PT SEK 400 Feb 2026
SDVKY analyst rating: Barclays maintains Overweight and raises PT to SEK 400 on Feb 25, 2026
^NDX Today: February 26 — SOTU Guests Flag AI Education, Drug Prices
^NDX edges near 25,000 as Melania Trump’s SOTU guest list spotlights AI education while White House guests stress drug-cost savings. What Canadian investors should watch today.
Citi Maintains Neutral on HNNMY (H & M Hennes & Mauritz AB) Feb 25, 2026
Citi maintains Neutral on HNNMY analyst rating, raises price target to SEK 174 on Feb 25, 2026
^GSPC Today, February 26: SOTU Clash Flags Tariff, Drug-Price Risks
^GSPC steadies near 6,890 as Abigail Spanberger SOTU rebutt spotlights Trump tariff policy and prescription drug prices. What GB investors should watch on healthcare cost transparency, sectors, and US
Morgan Stanley Maintains Underweight on Boliden AB (publ) BDNNY Feb 25 2026
Morgan Stanley kept Underweight and raised the price target for Boliden; BDNNY analyst rating, implications, and Meyka Grade B+
CHF17.32 pre-market: Gerresheimer AG (GXI.SW, SIX) top loser Feb 2026 outlook
Pre-market: GXI.SW stock falls to CHF17.32 (-73.42%). Quick analysis of drivers, Meyka grade and forecast